Bio Break: From Concept to Clinical
In this episode of Bio Break, Nick Allan and Joris van der Heijden revisit one of StarFish Medical’s most successful Pathfinder journeys, showcasing how a bold research concept evolved into a fully realized clinical diagnostic device.
The story begins over a decade ago when a client approached StarFish Medical with a breakthrough breath diagnostic concept. Their research had identified a unique analyte detectable in breath samples that promised a much clearer and faster diagnosis than existing tests. But the concept was still in its infancy and needed structured guidance, funding, and technical grounding to become a real medical device.
This is where the Pathfinder Program came in. The client engaged StarFish Medical to map out the best route to commercialization. The team produced a 200-page Pathfinder report packed with competitive analysis, target product profile development, reimbursement strategy, and detailed intellectual property evaluations. The industrial design team contributed stunning photorealistic renders, which became key assets in investor presentations and helped secure critical early funding.
With a clear path defined, StarFish Medical moved forward with iterative prototyping. Initial functional mock-ups helped evaluate sensors and control systems, leading to a clinical-ready prototype used in preliminary trials. The device performed beautifully, validating the original hypothesis and paving the way for final development stages.
Years later, that device is now in market, delivering accurate diagnoses and changing patients’ lives. In fact, during a MedTech conference, a user of the device approached the StarFish Medical team to share how it had transformed their health and lifestyle.
This new Bio Break episode is a powerful example of how Pathfinder engagements at StarFish Medical accelerate medical device innovation. It’s about more than a report—it’s about unlocking ideas, de-risking decisions, and setting a strong foundation for MedTech success.
Related Resources

Jason McGee explores how the Rightness Trap Medtech dynamic can quietly erode enterprise value in medical device companies.

Understanding gram positive vs negative bacteria is essential when studying sterility, microbiology, and antibiotic effectiveness. While many people think the difference is only about staining, the reality is much deeper.

Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.

Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.